CNE100002R81
CNE100002R81
SHANGHAI RONGTAI HEALTH TECHNOL
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 3.62B EUR | 3.41B EUR | 3.99B EUR |
Enterprise Value | 2.27B EUR | 3.4B EUR | 3.81B EUR |
Valuation Multiples | |||
Trailing P/E | 20.01x | 17.63x | 20.47x |
Forward P/E | 11.12x | -- | -- |
Price to Sales | 2.06x | 1.86x | 2.38x |
Price to Book | 1.29x | 1.24x | 1.39x |
EV/Revenue | 1.3x | 1.85x | 2.27x |
EV/EBITDA | 29.04x | 19.1x | 18.59x |
Price to FCF (P/FCF) | -- | 19.64x | 95.63x |
EV/FCF | -- | 19.54x | 91.28x |
FCF Yield | -1.78% | 5.09% | 1.05% |